Article info

PDF
Original Article
Penetrance estimates for BRCA1, BRCA2 (also applied to Lynch syndrome) based on presymptomatic testing: a new unbiased method to assess risk?

Authors

  • D Gareth Evans Division of Evolution and Genomic Science, Manchester Centre for Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Manchester, UKManchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UKPrevent Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Emma Woodward Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Elaine F Harkness Prevent Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UKDivision of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Anthony Howell Prevent Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UKDepartment of Medical Oncology, Christie Hospital, Manchester, UK PubMed articlesGoogle scholar articles
  • Inga Plaskocinska Department of Medical Genetics, Cancer Research UK Cambridge Centre, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK PubMed articlesGoogle scholar articles
  • Eamonn R Maher Department of Medical Genetics, Cancer Research UK Cambridge Centre, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK PubMed articlesGoogle scholar articles
  • Marc D Tischkowitz Department of Medical Genetics, Cancer Research UK Cambridge Centre, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK PubMed articlesGoogle scholar articles
  • Fiona Lalloo Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor D Gareth Evans, Manchester Centre for Genomic Medicine, St. Mary’s Hospital, Manchester M13 9WL, UK; gareth.evans{at}mft.nhs.uk
View Full Text

Citation

Evans DG, Woodward E, Harkness EF, et al
Penetrance estimates for BRCA1, BRCA2 (also applied to Lynch syndrome) based on presymptomatic testing: a new unbiased method to assess risk?

Publication history

  • Received December 17, 2017
  • Revised January 29, 2018
  • Accepted February 11, 2018
  • First published February 26, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.